Sana Biotechnology, Inc. Net Income Loss

Quick Answer

Sana Biotechnology, Inc. reported Net Income Loss of -$244.17 million for the year ending 2025.

  • Sana Biotechnology, Inc. showed an increase of +8.5% in Net Income Loss from 2024 to 2025.
  • This data is from Sana Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Sana Biotechnology, Inc.'s Net Income Loss has declined by 86.7%.
  • Historical annual values: Fiscal year 2025: -$244.17 million | Fiscal year 2024: -$266.76 million | Fiscal year 2023: -$283.26 million | Fiscal year 2022: -$269.48 million | Fiscal year 2021: -$355.93 million | Fiscal year 2020: -$285.31 million | Fiscal year 2019: -$130.78 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: